Navigation Links
Stroke victims have new hope with activated protein C

A new study by researchers from the University of Rochester, New York suggests that the activated protein C (APC), a protein with anti-inflammatory and anti-coagulant properties,which until now is being used to treat septic infections, may also help reduce the damage caused by stroke. Researchers who conducted the study on mice found that APC could protect brain cells from the secondary damage associated with ischemic stroke by preventing apoptosis, a form of programmed cell death. The study has shown// that APC reduced apoptosis by 65 per cent and neurological deficits by 91 per cent when given to mice following a stroke. Currently, only tissue plasminogen activator is useful for the 80 per cent of strokes that involve a blood clot, but can damage cells if given after the first few hours.

Further analysis by this team of researchers has shown that APC blocks p53, a molecule that drives cells towards apoptosis following stroke. APC works through two cellular receptors, called endothelial protein C receptor and protease-activated receptor 1, to reduce the level of p53 in damaged cells by 75 per cent. APC also increases anti-apoptotic signals that instruct cells to survive. Researchers concluded that the compound which is working in a completely unexpected way could spur further research to help develop treatments that reduce the lifelong disability often associated with stroke.


'"/>




Page: 1

Related medicine news :

1. Amphetamines Help Recovery of Stroke Patients
2. Cough Syrup Ingredient Linked to Stroke
3. Estrogen Does Not Prevent Recurrent Strokes
4. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
5. Triglycerides Linked To Stroke Risk
6. Strokes increased during squatting
7. Drug Combinations May Boost Stroke Risk
8. Stroke and Dementia - a ghastly association
9. Stroke risk might be linked to antibody
10. Stroke Risk and Fish :A factual interconnection
11. Fewer teeth & Increased Ischemic Stroke risk
Post Your Comments:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 1New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 2New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 3New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 4FoodBizDaily com Announces New Free Report International Trade Opportunity 3A The Brazilian Acai Berry 54107 1FoodBizDaily com Announces New Free Report International Trade Opportunity 3A The Brazilian Acai Berry 54107 2Imagenetix Inc Reports First Quarter 2010 Results 13476 1Imagenetix Inc Reports First Quarter 2010 Results 13476 2Imagenetix Inc Reports First Quarter 2010 Results 13476 3Imagenetix Inc Reports First Quarter 2010 Results 13476 4Imagenetix Inc Reports First Quarter 2010 Results 13476 5